Midi Health raises $50 million in funding as the menopause startup bets on longevity and AI

"Midi, which provides virtual care for perimenopause, menopause, and other midlife women's health conditions, has raised $50 million in a Series C round led by Advance Venture Partners. The raise brings its total funding to about $150 million.Cofounder and CEO Joanna Strober confirmed the raise in an interview with BI. Midi has a $150 million revenue run rate, Strober said, up from about $60 million at the end of 2024."

"Its rise reflects a slow but steady shift in how the healthcare market treats midlife women: employers are adding menopause care to their benefits, venture dollars are flowing, celebrities are speaking up, and a once-taboo topic is entering the mainstream. Midi offers personalized care that can include hormonal and non-hormonal medications, blood and genetic testing, lifestyle coaching, and supplements. The startup is now serving about 20,000 women every week, Strober said, roughly double its patient base in January."

Midi Health provides virtual care for perimenopause, menopause, and midlife women's health conditions and raised $50 million in a Series C, bringing total funding to about $150 million. The company reached a $150 million revenue run rate, up from about $60 million at the end of 2024, and now serves roughly 20,000 women weekly. Services include hormonal and non-hormonal medications, blood and genetic testing, lifestyle coaching, supplements, and a new longevity program. Midi is developing an AI search engine focused on women's health to address outdated or inaccurate information from existing AI tools.

Read at Business Insider